Your browser doesn't support javascript.
loading
Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial.
Ji, Linong; Lu, Jinmiao; Gao, Leili; Ying, Changjiang; Sun, Jiao; Han, Jie; Zhao, Wenhua; Gao, Yunming; Wang, Kun; Zheng, Xin; Xie, Daosheng; Ding, Juping; Zhao, Jiahong; Yu, Qiang; Wang, Tong.
Afiliación
  • Ji L; Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
  • Lu J; CGeneTech Co., Ltd, Suzhou, China.
  • Gao L; Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
  • Ying C; Department of Endocrinology and Metabolism, Peking University People's Hospital, Beijing, China.
  • Sun J; Department of Endocrinology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Han J; Department of Endocrinology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
  • Zhao W; Department of Endocrinology, Hebei Petro China Central Hospital, Langfang, China.
  • Gao Y; Department of Endocrinology, Pepole's Hospital of Changzhi City, Changzhi, China.
  • Wang K; Department of Endocrinology, The Second Pepole's Hospital of Lianyungang, Lianyungang, China.
  • Zheng X; Department of Endocrinology, Nanjing Jiangning Hospital, Nanjing, China.
  • Xie D; Department of Endocrinology, Beijing Boai Hospital, Beijing, China.
  • Ding J; Beijing Noahpharm Medical Technology Co., Ltd, Beijing, China.
  • Zhao J; CGeneTech Co., Ltd, Suzhou, China.
  • Yu Q; CGeneTech Co., Ltd, Suzhou, China.
  • Wang T; CGeneTech Co., Ltd, Suzhou, China.
Diabetes Obes Metab ; 25(12): 3671-3681, 2023 12.
Article en En | MEDLINE | ID: mdl-37661308

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Diabetes Obes Metab Asunto de la revista: ENDOCRINOLOGIA / METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: China